Molecular insights into uremic cardiomyopathy: Cardiotonic steroids and NA/K ATPase signaling

Cellular and Molecular Biology

Volumn 52, Issue 8, 2006, Pages 3-14

  Kennedy, D J ^a   Malhotra, D ^a   Shapiro, J I ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Cardiomyopathy; Fibrosis; Oxidant stress; Renal failure; Review; Sarcoplasmic reticulum CA2+ ATPase; Sodium potassium ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM; CARDIOTONIC STEROID; EPIDERMAL GROWTH FACTOR RECEPTOR; MARINOBUFAGENIN; MESSENGER RNA; PROTEIN TYROSINE KINASE; STEROID HORMONE; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; BLOOD PRESSURE REGULATION; CALCIUM CELL LEVEL; CARDIOMYOPATHY; CELLULAR STRESS RESPONSE; CELLULAR STRESS SIGNAL; CHRONIC KIDNEY DISEASE; DIASTOLIC DYSFUNCTION; HEART CELL CULTURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART MUSCLE RELAXATION; HUMAN; KIDNEY FAILURE; NONHUMAN; OXIDATIVE STRESS; PARTIAL NEPHRECTOMY; PATHOPHYSIOLOGY; PROTEIN PHOSPHORYLATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; TRANSACTIVATION; UREMIA;

BLOOD PRESSURE; CARDIAC GLYCOSIDES; CARDIOMYOPATHIES; FIBROSIS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; NA(+)-K(+)-EXCHANGING ATPASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 34249109098     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/T753     Document Type: Review

References (158)

1. Causes of death. USRDS. United States Renal Data System. Am. J. Kidney Dis. 1997, 30: S107-117.
2. Abe, J., Okuda, M., Huang, Q., Yoshizumi, M., and Berk, B.C. Reactive oxygen species activate p90 ribosomal S6 kinase via Fyn and Ras. J. Biol. Chem. 2000, 275: 1739-1748.
3. Abe, J.-i. and Berk, B.C. Reactive Oxygen Species as Mediators of Signal Transduction in Cardiovascular Disease. Trends Cardiovasc. Med. 1998, 8: 59.
4. Adachi, T., Weisbrod, R.M., Pimentel, D.R., Ying, J., Sharov, V.S., Schoneich, C., and Cohen, R.A. SGlutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat. Med. 2004, 10: 1200-1207.
5. Allen, J.C., Abramowitz, J., and Koksoy, A. Low concentrations of ouabain activate vascular smooth muscle cell proliferation. Ann. N. Y. Acad. Sci. 2003, 986: 504-508.
6. Amann, K. and Ritz, E. Cardiac disease in chronic uremia: pathophysiology. Adv. Ren. Replace. Ther. 1997, 4: 212-224.
7. Amici, A., Levine, R.L., Tsai, L., and Stadtman, E.R. Conversion of amino acid residues in proteins and amino acid homopolymers to carbonyl derivatives by metalcatalyzed oxidation reactions. J. Biol. Chem. 1989, 264: 3341-3346.
8. Aoyagi, T., Yonekura, K., Eto, Y., Matsumoto, A., Yokoyama, I., Sugiura, S., Momomura, S., Hirata, Y., Baker, D.L., and Periasamy, M. The sarcoplasmic reticulum Ca2+-ATPase (SERCA2) gene promoter activity is decreased in response to severe left ventricular pressureoverload hypertrophy in rat hearts. J. Mol. Cell. Cardiol. 1999, 31: 919-926.
9. Aydemir-Koksoy, A., Abramowitz, J., and Allen, J.C. Ouabain-induced signaling and vascular smooth muscle cell proliferation. J. Biol. Chem. 2001, 276: 46605-46611.
10. Bader, M. Role of the local renin-angiotensin system in cardiac damage: a minireview focussing on transgenic animal models. J. Mol. Cell. Cardiol. 2002, 34: 1455-1462.
11. Bagrov, A.Y. and Fedorova, O.V. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries. J. Hypertens. 1998, 16: 1953-1958.
12. Barnes, K.A., Samson, S.E., and Grover, A.K. Sarco/endoplasmic reticulum Ca2+-pump isoform SERCA3a is more resistant to superoxide damage than SERCA2b. Mol. Cell. Biochem. 2000, 203: 17-21.
13. Bartram, U. and Speer, C.P. The role of transforming growth factor beta in lung development and disease. Chest. 2004, 125: 754-765.
14. Bassani, J.W., Bassani, R.A., and Bers, D.M. Relaxation in rabbit and rat cardiac cells: species-dependent differences in cellular mechanisms. J Physiol. 1994, 476: 279-293.
15. Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A., and Freeman, B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U. S. A. 1990, 87: 1620-1624.
16. Bers, D.M. Cardiac excitation-contraction coupling. Nature. 2002, 415: 198-205.
17. Besarab, A. and Aslam, M. Should the hematocrit (hemoglobin) be normalized in Pre-ESRD or dialysis patients? Yes! Blood Purif. 2001, 19: 168-174.
18. Blaustein, M.P. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am. J. Physiol. 1977, 232: C165-173.
19. Bolognesi, R., Cucchini, F., Javernaro, A., Zeppellini, R., Manca, C., and Visioli, O. Effects of acute K-strophantidin administration on left ventricular relaxation and filling phase in coronary artery disease. Am. J. Cardiol. 1992, 69: 169-172.
20. Bolognesi, R., Manca, C., and Visioli, O. [Effects of digitalis on the diastolic phase of the normal heart. Angiographic evaluation in man]. Cardiologia. 1988, 33: 589-593.
21. Bolognesi, R., Reggiani, A., Piazza, A., Barilli, A.L., and Manca, C. [Effects of digitalis on the left ventricular filling phase in the normal and ischemic heart. Angiographic study in man]. Cardiologia. 1989, 34: 419-424.
22. Border, W.A. and Noble, N.A. Transforming growth factor beta in tissue fibrosis. N. Engl. J. Med. 1994, 331: 1286-1292.
23. Bricker, N.S. The control of sodium excretion with normal and reduced nephron populations. The preeminence of third factor. Am. J. Med. 1967, 43: 313-321.
24. Bricker, N.S. On the pathogenesis of the uremic state. An exposition of the "trade-off hypothesis". N. Engl. J. Med. 1972, 286: 1093-1099.
25. Brilla, C.G. Renin-angiotensin-aldosterone system and myocardial fibrosis. Cardiovasc. Res. 2000, 47: 1-3.
26. Brilla, C.G., Zhou, G., Matsubara, L., and Weber, K.T. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J. Mol. Cell. Cardiol. 1994, 26: 809-820.
27. Brown, N.J. Aldosterone and end-organ damage. Curr. Opin. Nephrol. Hypertens. 2005, 14: 235-241.
28. Cai, J. and Jones, D.P. Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss. J. Biol. Chem. 1998, 273: 11401-11404.
29. Chan, H.W., Smith, N.J., Hannan, R.D., and Thomas, W.G. Tackling the EGFR in pathological tissue remodelling. Pulm. Pharmacol. Ther. 2006, 19: 74-78.
30. Chen, K., Vita, J.A., Berk, B.C., and Keaney, J.F., Jr. c-Jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves SRC-dependent epidermal growth factor receptor transactivation. J. Biol. Chem. 2001, 276: 16045-16050. Epub 12001 Feb 16027.
31. Dahl, L.K., Knudsen, K.D., Heine, M., and Leitl, G. Effects of chronic excess salt ingestion. Genetic influence on the development of salt hypertension in parabiotic rats: evidence for a humoral factor. J. Exp. Med. 1967, 126: 687-699.
32. de Wardener, H.E. Franz Volhard Lecture 1996. Sodium transport inhibitors and hypertension. J. Hypertens. Suppl. 1996, 14: S9-18.
33. de Wardener, H.E. and Clarkson, E.M. Concept of natriuretic hormone. Physiol. Rev. 1985, 65: 658-759.
34. Delcayre, C. and Swynghedauw, B. Molecular mechanisms of myocardial remodeling. The role of aldosterone. J. Mol. Cell. Cardiol. 2002, 34: 1577-1584.
35. Dong, X.H., Komiyama, Y., Nishimura, N., Masuda, M., and Takahashi, H. Nanomolar level of ouabain increases intracellular calcium to produce nitric oxide in rat aortic endothelial cells. Clin. Exp. Pharmacol. Physiol. 2004, 31: 276-283.
36. Eisner, D.A. and Trafford, A.W. Heart failure and the ryanodine receptor: does Occam's razor rule? Circ. Res. 2002, 91: 979-981.
37. Fedorova, O.V., Agalakova, N.I., Talan, M.I., Lakatta, E.G., and Bagrov, A.Y. Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats. J. Hypertens. 2005, 23: 1515-1523.
38. Fedorova, O.V., Anderson, D.E., and Bagrov, A.Y. Plasma marinobufagenin-like and ouabain-like immunoreactivity in adrenocorticotropin- treated rats. Am. J. Hypertens. 1998, 11: 796-802.
39. Fedorova, O.V., Doris, P.A., and Bagrov, A.Y. Endogenous marinobufagenin-like factor in acute plasma volume expansion. Clin. Exp. Hypertens. 1998, 20: 581-591.
40. Fedorova, O.V., Talan, M.I., Agalakova, N.I., Lakatta, E.G., and Bagrov, A.Y. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride - dependent hypertension. Circulation. 2002, 105: 1122-1127.
41. Foley, R.N., Parfrey, P.S., Harnett, J.D., Kent, G.M., Martin, C.J., Murray, D.C., and Barre, P.E. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995, 47: 186-192.
42. Foley, R.N., Parfrey, P.S., Kent, G.M., Harnett, J.D., Murray, D.C., and Barre, P.E. Serial change in echocardiographic parameters and cardiac failure in endstage renal disease. J. Am. Soc. Nephrol. 2000, 11: 912-916.
43. Foley, R.N., Parfrey, P.S., and Sarnak, M.J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis. 1998, 32: S112-119.
44. Funck, R.C., Wilke, A., Rupp, H., and Brilla, C.G. Regulation and role of myocardial collagen matrix remodeling in hypertensive heart disease. Adv. Exp. Med. Biol. 1997, 432: 35-44.
45. Funder, J. Mineralocorticoids and cardiac fibrosis: the decade in review. Clin. Exp. Pharmacol. Physiol. 2001, 28: 1002-1006.
46. Galli, F., Canestrari, F., and Buoncristiani, U. Biological effects of oxidant stress in haemodialysis: the possible roles of vitamin E. Blood Purif. 1999, 17: 79-94.
47. Garg, A.X., Clark, W.F., Haynes, R.B., and House, A.A. Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int. 2002, 61: 1486-1494.
48. Gottlieb, S.S., Rogowski, A.C., Weinberg, M., Krichten, C.M., Hamilton, B.P., and Hamlyn, J.M. Elevated concentrations of endogenous ouabain in patients with congestive heart failure. Circulation. 1992, 86: 420-425.
49. Greene, E.L., Kren, S., and Hostetter, T.H. Role of aldosterone in the remnant kidney model in the rat. J. Clin. Invest. 1996, 98: 1063-1068.
50. Gressner, A.M., Weiskirchen, R., Breitkopf, K., and Dooley, S. Roles of TGF-beta in hepatic fibrosis. Front. Biosci. 2002, 7: d793-807.
51. Grover, A.K. and Samson, S.E. Peroxide resistance of ER Ca2+ pump in endothelium: implications to coronary artery function. Am. J. Physiol. 1997, 273: C1250-1258.
52. Grover, A.K., Samson, S.E., and Misquitta, C.M. Sarco(endo)plasmic reticulum Ca2+ pump isoform SERCA3 is more resistant than SERCA2b to peroxide. Am. J. Physiol. 1997, 273: C420-425.
53. Haas, M., Askari, A., and Xie, Z. Involvement of Src and epidermal growth factor receptor in the signaltransducing function of Na+/K+-ATPase. J. Biol. Chem. 2000, 275: 27832-27837.
54. Haas, M., Wang, H., Tian, J., and Xie, Z. Srcmediated inter-receptor cross-talk between the Na+/K+-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases. J. Biol. Chem. 2002, 277: 18694-18702.
55. Hamlyn, J.M., Lu, Z.R., Manunta, P., Ludens, J.H., Kimura, K., Shah, J.R., Laredo, J., Hamilton, J.P., Hamilton, M.J., and Hamilton, B.P. Observations on the nature, biosynthesis, secretion and significance of endogenous ouabain. Clin. Exp. Hypertens. 1998, 20: 523-533.
56. Hamlyn, J.M. and Manunta, P. Ouabain, digitalislike factors and hypertension. J. Hypertens. Suppl. 1992, 10: S99-111.
57. Hartong, R., Wang, N., Kurokawa, R., Lazar, M.A., Glass, C.K., Apriletti, J.W., and Dillmann, W.H. Delineation of three different thyroid hormone-response elements in promoter of rat sarcoplasmic reticulum Ca2+ATPase gene. Demonstration that retinoid X receptor binds 5′ to thyroid hormone receptor in response element 1. J. Biol. Chem. 1994, 269: 13021-13029.
58. Hasegawa, T., Masugi, F., Ogihara, T., and Kumahara, Y. Increase in plasma ouabainlike inhibitor of Na+, K+-ATPase with high sodium intake in patients with essential hypertension. J. Clin. Hypertens. 1987, 3: 419-429.
59. Henry, R.M., Kostense, P.J., Bos, G., Dekker, J.M., Nijpels, G., Heine, R.J., Bouter, L.M., and Stehouwer, C.D. Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int. 2002, 62: 1402-1407.
60. Heymans, S. Inflammation and cardiac remodeling during viral myocarditis. Ernst Schering Res Found Workshop. 2006, 197-218.
61. Hill, C.S. The Smads. Int. J. Biochem. Cell Biol. 1999, 31: 1249-1254.
62. Hostetter, T.H., Olson, J.L., Rennke, H.G., Venkatachalam, M.A., and Brenner, B.M. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am. J. Physiol. 1981, 241: F85-93.
63. Hove-Madsen, L. and Bers, D.M. Sarcoplasmic reticulum Ca2+ uptake and thapsigargin sensitivity in permeabilized rabbit and rat ventricular myocytes. Circ. Res. 1993, 73: 820-828.
64. Huang, L., Li, H., and Xie, Z. Ouabain-induced hypertrophy in cultured cardiac myocytes is accompanied by changes in expression of several late response genes. J. Mol. Cell. Cardiol. 1997, 29: 429-437.
65. Ihn, H. The role of TGF-beta signaling in the pathogenesis of fibrosis in scleroderma. Arch. Immunol. Ther. Exp. (Warsz). 2002, 50: 325-331.
66. Investigators, T.R. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]). Am. J. Cardiol. 1996, 78: 902-907.
67. Javelaud, D. and Mauviel, A. Mammalian transforming growth factor-betas: Smad signaling and physio-pathological roles. Int. J. Biochem. Cell Biol. 2004, 36: 1161-1165.
68. Javelaud, D. and Mauviel, A. Transforming growth factor-betas: smad signaling and roles in physiopathology. Pathol. Biol. (Paris). 2004, 52: 50-54.
69. Kawamura, A., Guo, J., Itagaki, Y., Bell, C., Wang, Y., Haupert, G.T., Jr., Magil, S., Gallagher, R.T., Berova, N., and Nakanishi, K. On the structure of endogenous ouabain. Proc. Natl. Acad. Sci. U. S. A. 1999, 96: 6654-6659.
70. Kennedy, D., Omran, E., Periyasamy, S.M., Nadoor, J., Priyadarshi, A., Willey, J.C., Malhotra, D., Xie, Z., and Shapiro, J.I. Effect of chronic renal failure on cardiac contractile function, calcium cycling, and gene expression of proteins important for calcium homeostasis in the rat. J. Am. Soc. Nephrol. 2003, 14: 90-97.
71. Kennedy, D.J., Vetteth, S., Periyasamy, S.M., Kanj, M., Fedorova, L., Khouri, S., Kahaleh, M.B., Xie, Z., Malhotra, D., Kolodkin, N.I., Lakatta, E.G., Fedorova, O.V., Bagrov, A.Y., and Shapiro, J.I. Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension. 2006, 47: 488-495.
72. Kometiani, P., Li, J., Gnudi, L., Kahn, B.B., Askari, A., and Xie, Z. Multiple signal transduction pathways link Na+/K+-ATPase to growth-related genes in cardiac myocytes. The roles of Ras and mitogen-activated protein kinases. J. Biol. Chem. 1998, 273: 15249-15256.
73. Komiyama, Y., Dong, X.H., Nishimura, N., Masaki, H., Yoshika, M., Masuda, M., and Takahashi, H. A novel endogenous digitalis, telocinobufagin, exhibits elevated plasma levels in patients with terminal renal failure. Clin. Biochem. 2005, 38: 36-45.
74. Koss, K.L. and Kranias, E.G. Phospholamban: a prominent regulator of myocardial contractility. Circ. Res. 1996, 79: 1059-1063.
75. Lehnart, S.E., Schillinger, W., Pieske, B., Prestle, J., Just, H., and Hasenfuss, G. Sarcoplasmic reticulum proteins in heart failure. Ann. N. Y. Acad. Sci. 1998, 853: 220-230.
76. Lijnen, P. and Petrov, V. Induction of cardiac fibrosis by aldosterone. J. Mol. Cell. Cardiol. 2000, 32: 865-879.
77. Little, W.C., Rassi, A., Jr., and Freeman, G.L. Comparison of effects of dobutamine and ouabain on left ventricular contraction and relaxation in closed-chest dogs. J. Clin. Invest. 1987, 80: 613-620.
78. Liu, J., Kesiry, R., Periyasamy, S.M., Malhotra, D., Xie, Z., and Shapiro, J.I. Ouabain induces endocytosis of plasmalemmal Na/K-ATPase in LLC-PK1 cells by a clathrin-dependent mechanism. Kidney Int. 2004, 66: 227-241.
79. Liu, J., Liang, M., Liu, L., Malhotra, D., Xie, Z., and Shapiro, J.I. Ouabain-induced endocytosis of the plasmalemmal Na/K-ATPase in LLC-PK1 cells requires caveolin-1. Kidney Int. 2005, 67: 1844-1854.
80. Liu, J., Periyasamy, S.M., Gunning, W., Fedorova, O.V., Bagrov, A.Y., Malhotra, D., Xie, Z., and Shapiro, J.I. Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells. Kidney Int. 2002, 62: 2118-2125.
81. Liu, J., Tian, J., Haas, M., Shapiro, J.I., Askari, A., and Xie, Z. Ouabain interaction with cardiac Na+/K+-ATPase initiates signal cascades independent of changes in intracellular Na+ and Ca2+ concentrations. J. Biol. Chem. 2000, 275: 27838-27844.
82. Liu, L., Mohammadi, K., Aynafshar, B., Wang, H., Li, D., Liu, J., Ivanov, A.V., Xie, Z., and Askari, A. Role of caveolae in signal-transducing function of cardiac Na+/K+-ATPase. Am J Physiol Cell Physiol. 2003, 284: C1550-1560.
83. London, G.M. and Parfrey, P.S. Cardiac disease in chronic uremia: pathogenesis. Adv. Ren. Replace. Ther. 1997, 4: 194-211.
84. Lopez Farre, A. and Casado, S. Heart failure, redox alterations, and endothelial dysfunction. Hypertension. 2001, 38: 1400-1405.
85. McGuane, J.T. and Parry, L.J. Relaxin and the extracellular matrix: molecular mechanisms of action and implications for cardiovascular disease. Expert Rev Mol Med. 2005, 7: 1-18.
86. Mercadier, J.J., Lompre, A.M., Duc, P., Boheler, K.R., Fraysse, J.B., Wisnewsky, C., Allen, P.D., Komajda, M., and Schwartz, K. Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure. J. Clin. Invest. 1990, 85: 305-309.
87. Middleton, R.J., Parfrey, P.S., and Foley, R.N. Left ventricular hypertrophy in the renal patient. J. Am. Soc. Nephrol. 2001, 12: 1079-1084.
88. Mitsnefes, M.M., Daniels, S.R., Schwartz, S.M., Khoury, P., and Strife, C.F. Changes in left ventricular mass in children and adolescents during chronic dialysis. Pediatr. Nephrol. 2001, 16: 318-323.
89. Nakazato, T., Kawada, T., Shigematsu, T., and Yamada, K. Left ventricular hypertrophy was infrequent in patients starting dialysis after undergoing a strict blood pressure control in the pre-dialytic period. Intern. Med. 2002, 41: 925-930.
90. Nath, K.A. and Paller, M.S. Dietary deficiency of antioxidants exacerbates ischemic injury in the rat kidney. Kidney Int. 1990, 38: 1109-1117.
91. Nishio, M., Ruch, S.W., Kelly, J.E., Aistrup, G.L., Sheehan, K., and Wasserstrom, J.A. Ouabain increases sarcoplasmic reticulum calcium release in cardiac myocytes. J. Pharmacol. Exp. Ther. 2004, 308: 1181-1190. Epub 2003 Nov 1121.
92. Nishio, M., Ruch, S.W., and Wasserstrom, J.A. Positive inotropic effects of ouabain in isolated cat ventricular myocytes in sodium-free conditions. Am J Physiol Heart Circ Physiol. 2002, 283: H2045-2053.
93. Orlandi, A., Francesconi, A., Marcellini, M., Ferlosio, A., and Spagnoli, L.G. Role of ageing and coronary atherosclerosis in the development of cardiac fibrosis in the rabbit. Cardiovasc. Res. 2004, 64: 544-552.
94. Oweis, S., Wu, L., Kiela, P.R., Zhao, H., Malhotra, D., Ghishan, F.K., Xie, Z., Shapiro, J.I., and Liu, J. Cardiac glycoside downregulates NHE3 activity and expression in LLC-PK1 cells. Am J Physiol Renal Physiol. 2006, 290: F997-F1008.
95. Parfrey, P.S. Is renal insufficiency an atherogenic state? Reflections on prevalence, incidence, and risk. Am. J. Kidney Dis. 2001, 37: 154-156.
96. Periyasamy, S.M., Chen, J., Cooney, D., Carter, P., Omran, E., Tian, J., Priyadarshi, S., Bagrov, A., Fedorova, O., Malhotra, D., Xie, Z., and Shapiro, J.I. Effects of uremic serum on isolated cardiac myocyte calcium cycling and contractile function. Kidney Int. 2001, 60: 2367-2376.
97. Periyasamy, S.M., Liu, J., Tanta, F., Kabak, B., Wakefield, B., Malhotra, D., Kennedy, D.J., Nadoor, A., Fedorova, O.V., Gunning, W., Xie, Z., Bagrov, A.Y., and Shapiro, J.I. Salt loading induces redistribution of the plasmalemmal Na/K-ATPase in proximal tubule cells. Kidney Int. 2005, 67: 1868-1877.
98. Peterson, M.C. Circulating transforming growth factor beta-1: a partial molecular explanation for associations between hypertension, diabetes, obesity, smoking and human disease involving fibrosis. Med Sci Monit. 2005, 11: RA229-232.
99. Priyadarshi, S., Valentine, B., Han, C., Fedorova, O.V., Bagrov, A.Y., Liu, J., Periyasamy, S.M., Kennedy, D., Malhotra, D., Xie, Z., and Shapiro, J.I. Effect of green tea extract on cardiac hypertrophy following 5/6 nephrectomy in the rat. Kidney Int. 2003, 63: 1785-1790.
100. Radi, R., Beckman, J.S., Bush, K.M., and Freeman, B.A. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 1991, 266: 4244-4250.
101. Raine, A.E., Seymour, A.M., Roberts, A.F., Radda, G.K., and Ledingham, J.G. Impairment of cardiac function and energetics in experimental renal failure. J. Clin. Invest. 1993, 92: 2934-2940.
102. Raj, D.S., D'Mello, S., Somiah, S., Sheeba, S.D., and Mani, K. Left ventricular morphology in chronic renal failure by echocardiography. Ren. Fail. 1997, 19: 799-806.
103. Remme, W.J. Pharmacological modulation of cardiovascular remodeling: a guide to heart failure therapy. Cardiovasc. Drugs Ther. 2003, 17: 349-360.
104. Rigatto, C., Parfrey, P., Foley, R., Negrijn, C., Tribula, C., and Jeffery, J. Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. J. Am. Soc. Nephrol. 2002, 13: 1084-1090.
105. Roberts, A.B., Russo, A., Felici, A., and Flanders, K.C. Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta. Ann. N. Y. Acad. Sci. 2003, 995: 1-10.
106. Rohrer, D.K., Hartong, R., and Dillmann, W.H. Influence of thyroid hormone and retinoic acid on slow sarcoplasmic reticulum Ca2+ ATPase and myosin heavy chain alpha gene expression in cardiac myocytes. Delineation of cis-active DNA elements that confer responsiveness to thyroid hormone but not to retinoic acid. J. Biol. Chem. 1991, 266: 8638-8646.
107. Rombouts, K., Wielant, A., Hellemans, K., Schuppan, D., and Geerts, A. Influence of aldosterone on collagen synthesis and proliferation of rat cardiac fibroblasts. Br. J. Pharmacol. 2001, 134: 224-232.
108. Rowe, G.T., Manson, N.H., Caplan, M., and Hess, M.L. Hydrogen peroxide and hydroxyl radical mediation of activated leukocyte depression of cardiac sarcoplasmic reticulum. Participation of the cyclooxygenase pathway. Circ. Res. 1983, 53: 584-591.
109. Ruiz-Ortega, M., Ruperez, M., Esteban, V., and Egido, J. Molecular mechanisms of angiotensin II-induced vascular injury. Curr Hypertens Rep. 2003, 5: 73-79.
110. Sabri, A., Byron, K.L., Samarel, A.M., Bell, J., and Lucchesi, P.A. Hydrogen peroxide activates mitogenactivated protein kinases and Na+-H+ exchange in neonatal rat cardiac myocytes. Circ. Res. 1998, 82: 1053-1062.
111. Sarnak, M.J., Levey, A.S., Schoolwerth, A.C., Coresh, J., Culleton, B., Hamm, L.L., McCullough, P.A., Kasiske, B.L., Kelepouris, E., Klag, M.J., Parfrey, P., Pfeffer, M., Raij, L., Spinosa, D.J., and Wilson, P.W. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003, 108: 2154-2169.
112. Schiller, M., Javelaud, D., and Mauviel, A. TGFbeta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J. Dermatol. Sci. 2004, 35: 83-92.
113. Schmidt, U., Hajjar, R.J., Helm, P.A., Kim, C.S., Doye, A.A., and Gwathmey, J.K. Contribution of abnormal sarcoplasmic reticulum ATPase activity to systolic and diastolic dysfunction in human heart failure. J. Mol. Cell. Cardiol. 1998, 30: 1929-1937.
114. Schnaper, H.W., Hayashida, T., Hubchak, S.C., and Poncelet, A.C. TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol. 2003, 284: F243-252.
115. Schoner, W. Endogenous cardiac glycosides, a new class of steroid hormones. Eur. J. Biochem. 2002, 269: 2440-2448.
116. Schotten, U., Koenigs, B., Rueppel, M., Schoendube, F., Boknik, P., Schmitz, W., and Hanrath, P. Reduced myocardial sarcoplasmic reticulum Ca(2+)-ATPase protein expression in compensated primary and secondary human cardiac hypertrophy. J. Mol. Cell. Cardiol. 1999, 31: 1483-1494.
117. Shapiro, J.I. Functional and metabolic responses of isolated hearts to acidosis: effects of sodium bicarbonate and Carbicarb. Am. J. Physiol. 1990, 258: H1835-1839.
118. Shivakumar, K. Pro-fibrogenic effects of magnesium deficiency in the cardiovascular system. Magnes. Res. 2002, 15: 307-315.
119. Smith, C.L. and Berkseth, R.O. Sensitivity of erythrocytes to oxidant stress in uremia. Am. J. Nephrol. 1990, 10: 61-68.
120. Spittle, M.A., Hoenich, N.A., Handelman, G.J., Adhikarla, R., Homel, P., and Levin, N.W. Oxidative stress and inflammation in hemodialysis patients. Am. J. Kidney Dis. 2001, 38: 1408-1413.
121. Stack, A.G. and Bloembergen, W.E. A crosssectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am. J. Kidney Dis. 2001, 38: 992-1000.
122. Stack, A.G. and Saran, R. Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States. Am. J. Kidney Dis. 2002, 40: 1202-1210.
123. Stadtman, E.R. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metalcatalyzed reactions. Annu. Rev. Biochem. 1993, 62: 797-821.
124. Suzuki, Y.J., Forman, H.J., and Sevanian, A. Oxidants as stimulators of signal transduction. Free Radic. Biol. Med. 1997, 22: 269-285.
125. Tabibzadeh, S. Homeostasis of extracellular matrix by TGF-beta and lefty. Front. Biosci. 2002, 7: d1231-1246.
126. Temsah, R.M., Netticadan, T., Chapman, D., Takeda, S., Mochizuki, S., and Dhalla, N.S. Alterations in sarcoplasmic reticulum function and gene expression in ischemic-reperfused rat heart. Am. J. Physiol. 1999, 277: H584-594.
127. Tetta, C., Biasioli, S., Schiavon, R., Inguaggiato, P., David, S., Panichi, V., and Wratten, M.L. An overview of haemodialysis and oxidant stress. Blood Purif. 1999, 17: 118-126.
128. Thuerauf, D.J., Hoover, H., Meller, J., Hernandez, J., Su, L., Andrews, C., Dillmann, W.H., McDonough, P.M., and Glembotski, C.C. Sarco/endoplasmic reticulum calcium ATPase-2 expression is regulated by ATF6 during the endoplasmic reticulum stress response: intracellular signaling of calcium stress in a cardiac myocyte model system. J. Biol. Chem. 2001, 276: 48309-48317. Epub 42001 Oct 48310.
129. Tian, J., Gong, X., and Xie, Z. Signal-transducing function of Na+-K+-ATPase is essential for ouabain's effect on [Ca2+]i in rat cardiac myocytes. Am J Physiol Heart Circ Physiol. 2001, 281: H1899-1907.
130. Tian, J., Liu, J., Garlid, K.D., Shapiro, J.I., and Xie, Z. Involvement of mitogen-activated protein kinases and reactive oxygen species in the inotropic action of ouabain on cardiac myocytes. A potential role for mitochondrial K(ATP) channels. Mol. Cell. Biochem. 2003, 242: 181-187.
131. Tyralla, K. and Amann, K. Morphology of the heart and arteries in renal failure. Kidney Int. Suppl. 2003, S80-83.
132. Usberti, M., Gerardi, G., Bufano, G., Tira, P., Micheli, A., Albertini, A., Floridi, A., Di Lorenzo, D., and Galli, F. Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed patients. Am. J. Kidney Dis. 2002, 40: 590-599.
133. Vasan, R.S., Larson, M.G., Benjamin, E.J., Evans, J.C., and Levy, D. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction [see comments]. N. Engl. J. Med. 1997, 336: 1350-1355.
134. Verrecchia, F. and Mauviel, A. Control of connective tissue gene expression by TGF beta: role of Smad proteins in fibrosis. Curr Rheumatol Rep. 2002, 4: 143-149.
135. Verrecchia, F. and Mauviel, A. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J. Invest. Dermatol. 2002, 118: 211-215.
136. Viner, R.I., Ferrington, D.A., Huhmer, A.F., Bigelow, D.J., and Schoneich, C. Accumulation of nitrotyrosine on the SERCA2a isoform of SR Ca-ATPase of rat skeletal muscle during aging: a peroxynitrite-mediated process? FEBS Lett. 1996, 379: 286-290.
137. Viner, R.I., Ferrington, D.A., Williams, T.D., Bigelow, D.J., and Schoneich, C. Protein modification during biological aging: selective tyrosine nitration of the SERCA2a isoform of the sarcoplasmic reticulum Ca2+-ATPase in skeletal muscle. Biochem. J. 1999, 340: 657-669.
138. Viner, R.I., Williams, T.D., and Schoneich, C. Nitric oxide-dependent modification of the sarcoplasmic reticulum Ca-ATPase: localization of cysteine target sites. Free Radic. Biol. Med. 2000, 29: 489-496.
139. Vu, H.V., Ianosi-Irimie, M.R., Pridjian, C.A., Whitbred, J.M., Durst, J.M., Bagrov, A.Y., Fedorova, O.V., Pridjian, G., and Puschett, J.B. Involvement of marinobufagenin in a rat model of human preeclampsia. Am. J. Nephrol. 2005, 25: 520-528.
140. Wakatsuki, T., Schlessinger, J., and Elson, E.L. The biochemical response of the heart to hypertension and exercise. Trends Biochem. Sci. 2004, 29: 609-617.
141. Ward, S.C., Hamilton, B.P., and Hamlyn, J.M. Novel receptors for ouabain: studies in adrenocortical cells and membranes. Hypertension. 2002, 39: 536-542.
142. Weber, K.T. Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair. Semin. Nephrol. 1997, 17: 467-491.
143. Weber, K.T. and Brilla, C.G. Myocardial fibrosis and the renin-angiotensin-aldosterone system. J. Cardiovasc. Pharmacol. 1992, 20 Suppl 1: S48-54.
144. Weber, K.T. and Brilla, C.G. Pathological hypertrophy and cardiac interstitium. Fibrosis and reninangiotensin-aldosterone system. Circulation. 1991, 83: 1849-1865.
145. Weber, K.T., Brilla, C.G., Campbell, S.E., Guarda, E., Zhou, G., and Sriram, K. Myocardial fibrosis: role of angiotensin II and aldosterone. Basic Res. Cardiol. 1993, 88 Suppl 1: 107-124.
146. Weiner, D.E., Tighiouart, H., Amin, M.G., Stark, P.C., MacLeod, B., Griffith, J.L., Salem, D.N., Levey, A.S., and Sarnak, M.J. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J. Am. Soc. Nephrol. 2004, 15: 1307-1315.
147. Xie, J., Wang, Y., Summer, W.R., and Greenberg, S.S. Ouabain enhances basal release of nitric oxide from carotid artery. Am. J. Med. Sci. 1993, 305: 157-163.
148. Xie, Z. Molecular mechanisms of Na/K-ATPasemediated signal transduction. Ann. N. Y. Acad. Sci. 2003, 986: 497-503.
149. Xie, Z. and Askari, A. Na(+)/K(+)-ATPase as a signal transducer. Eur. J. Biochem. 2002, 269: 2434-2439.
150. Xie, Z., Jack-Hays, M., Wang, Y., Periyasamy, S.M., Blanco, G., Huang, W.H., and Askari, A. Different oxidant sensitivities of the alpha 1 and alpha 2 isoforms of Na+/K(+)-ATPase expressed in baculovirus-infected insect cells. Biochem. Biophys. Res. Commun. 1995, 207: 155-159.
151. Xie, Z., Kometiani, P., Liu, J., Li, J., Shapiro, J.I., and Askari, A. Intracellular reactive oxygen species mediate the linkage of Na+/K+-ATPase to hypertrophy and its marker genes in cardiac myocytes. J. Biol. Chem. 1999, 274: 19323-19328.
152. Xie, Z. and Xie, J. The Na/K-ATPase-mediated signal transduction as a target for new drug development. Front. Biosci. 2005, 10: 3100-3109.
153. Yamada, S. and Ikemoto, N. Distinction of thiols involved in the specific reaction steps of the Ca2+-ATPase of the sarcoplasmic reticulum. J. Biol. Chem. 1978, 253: 6801-6807.
154. Yamazaki, T., Komuro, I., Shiojima, I., and Yazaki, Y. The molecular mechanism of cardiac hypertrophy and failure. Ann. N. Y. Acad. Sci. 1999, 874: 38-48.
155. Young, M. and Funder, J.W. Aldosterone and the heart. Trends Endocrinol Metab. 2000, 11: 224-226.
156. Young, M.J. and Funder, J.W. Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system. J. Hypertens. 2002, 20: 1465-1468.
157. Young, M.J. and Funder, J.W. Mineralocorticoids, salt, hypertension: effects on the heart. Steroids. 1996, 61: 233-235.
158. Zhang, Y. and Derynck, R. Transcriptional regulation of the transforming growth factor-beta -inducible mouse germ line Ig alpha constant region gene by functional cooperation of Smad, CREB, and AML family members. J. Biol. Chem. 2000, 275: 16979-16985.